This content is machine translated Diffuse large B-cell lymphoma T-cell-based therapy “off the shelf” Two types of T-cell-based therapy are available for refractory or relapsing diffuse large B-cell lymphoma (DLBCL): CAR T cells and bispecific antibodies. While CAR T cells have revolutionized individualized medicine…
View Post 3 min This content is machine translated Brain tumors Glioblastoma – the spectre of brain tumors Glioblastomas are a particularly aggressive form of brain tumor. To this day, they are incurable. Despite important advances in understanding the molecular pathogenesis and biology of this tumor over the…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Module Prostate Cancer Treatment options for prostate cancer have evolved rapidly over the past two years, with advances across the spectrum of disease stages. Prof. em. Dr. med Richard Herrmann speaks in the… CME-Test
View Post 11 min This content is machine translated Malignancies Therapy of esophageal carcinoma – an overview Esophageal carcinomas are comparatively rare tumors and account for approximately 1% of all malignancies worldwide. Based on their location, a distinction is made between cervical and intrathoracic tumors. Histologically, they… CME-Test
View Post 4 min This content is machine translated Aplastic anemia Etiology and severity as criteria for therapy selection Aplastic anemia is associated with bone marrow hypocellularity and pancytopenia. In patients with immune-mediated severe or very severe aplastic anemia for whom bone marrow transplantation is not an option, the…
View Post 4 min This content is machine translated Smoking cessation Nicotine in smoking cessation products – a contradiction? The health risks of smoking are now well known. Many efforts have been and are being made, not only by scientists but also by politicians, to minimize the risks. Alternatives…
View Post 3 min This content is machine translated Medical oncology Mastering challenges, shaping innovations Interdisciplinary networking and personal exchange of experience are essential for international cooperation. Around 5500 participants took part in the DGHO in Basel. The largest congress for the specialist field in…
View Post 1 min This content is machine translated Swiss Oncology in Motion SOiM Urothelial carcinoma – Update Oncology is constantly changing, with additional diagnostic procedures, new surgical methods and innovative therapeutic concepts being developed. For this reason, the treatment guidelines are also continuously revised. Therefore, this module… CME-Test
View Post 9 min This content is machine translated Pleural mesothelioma Development, diagnosis and treatment of the aggressive tumor Malignant pleural mesothelioma is an aggressive tumor originating in the pleura. Patients have a short life expectancy after diagnosis, partly due to the limited treatment options. Exposure to asbestos fibers… CME-Test
View Post 6 min This content is machine translated Essential thrombocythemia Risk assessment is of vital importance – a look at the data situation Essential thrombocythemia usually occurs after the age of 50, although there are also those affected under the age of 40. Various subtypes can be distinguished based on molecular genetic analyses.…
View Post 4 min This content is machine translated Immuno-oncological therapies CAR-T cell therapy for hematologic cancers Immunotherapies are now established pillars in the treatment of cancer. The principle of CAR-T cell therapy is that the body’s own T cells are programmed to destroy cancer cells through…
